Chengpei Zhu
机构：Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Beijing YouAn Hospital · ORCID：0000-0002-0291-782X
发表论文 57 篇 · 总被引 1135 次 · h-index 21
代表论文
- Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma (2024 · Journal for ImmunoTherapy of Cancer · 被引 45)
- Radiation Therapy With Combination Therapy of Immune Checkpoint Inhibitors and Antiangiogenic Therapy for Hepatocellular Carcinoma (2023 · International Journal of Radiation Oncology*Biology*Physics · 被引 39)
- Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer (2024 · Biomarker Research · 被引 37)
- Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study (2023 · Cancer Immunology Immunotherapy · 被引 34)
- Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma (2023 · World Journal of Gastroenterology · 被引 31)
- Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis (2023 · Cancer Immunology Immunotherapy · 被引 25)